Company Profile
Teleflex Stock Price, News & Analysis
- Ticker:
- TFX
- Exchange:
- NYSE
- Sector:
- MedTech
- Location:
- United States
Stock performance
138.89 USD (+1.54%)
Close
Last updated: August 6, 2026
5.54B USD
Market cap
Why the stock is moving
As of Aug 6, 2026, TFX closed up 1.54% at $138.89. No new same-company headline was identified in the current news window.
Company overview
Business overview
Teleflex is a medical technology company with products across anesthesia, vascular access, interventional, and surgical care. Its business is centered on procedure-linked devices used across acute care and hospital settings.
Geographic Base and Sector Classification
Headquartered in the United States and listed on NYSE, Teleflex has a global medtech footprint. It sits in medical devices rather than biotech or pharma.
Business Model Characteristics
The company generates revenue through device sales, consumables, and procedure-related products. Investors focus on hospital demand, product mix, supply execution, and margin trends.
Position Within the Biotechnology Landscape
Teleflex is outside biotech but important in healthcare technology because it serves procedure-driven clinical workflows. Its stock is driven by device adoption and hospital utilization, not trial data.
Future catalysts
Teleflex’s catalysts are product-cycle execution in connected care and urinary care, plus margin improvement from portfolio simplification. This matters because it helps show whether the company can turn its current footprint into a cleaner earnings profile. Better execution here can matter even before a new product or trial headline lands.
Recent news
- 01
Teleflex Announces Leadership Transition
Source: Teleflex
- 02
- 03
- 04
Teleflex Announces Quarterly Dividend
Source: Teleflex
- 05
Similar stocks
Peer names with similar commercial maturity, therapeutic overlap, or catalyst patterns.
Frequently Asked Questions
What is the current stock price of Teleflex (TFX)?
Teleflex (TFX) most recently closed at 138.89 USD, a +1.54% move versus the previous session.
What is the market cap of Teleflex (TFX)?
Teleflex currently has a market capitalization of 5.54B USD on BioPharmSignal.
What does Teleflex do?
Teleflex is a medical technology company with products across anesthesia, vascular access, interventional, and surgical care. Its business is centered on procedure-linked devices used across acute care and hospital settings.
On which exchange is TFX stock listed?
Teleflex (TFX) is associated with NYSE, United States, MedTech.
What is Teleflex?
Teleflex’s catalysts are product-cycle execution in connected care and urinary care, plus margin improvement from portfolio simplification.
Which conditions is Teleflex targeting with Teleflex?
Teleflex’s catalysts are product-cycle execution in connected care and urinary care, plus margin improvement from portfolio simplification.
How does Teleflex describe recent progress with Teleflex?
Teleflex’s catalysts are product-cycle execution in connected care and urinary care, plus margin improvement from portfolio simplification.
What is This?
This matters because it helps show whether the company can turn its current footprint into a cleaner earnings profile.